Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
304.8 USD | -1.36% | +1.33% | +11.25% |
04-26 | Align Technology to Buy Back $150 Million in Shares | MT |
04-25 | Baird Adjusts Price Target on Align Technology to $370 From $333 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 42.68 and 35.94 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.25% | 22.94B | C+ | ||
-2.54% | 186B | C+ | ||
-1.85% | 107B | C | ||
-4.26% | 67.44B | A | ||
+1.39% | 50.03B | B- | ||
+16.82% | 47.81B | B- | ||
+4.79% | 41.03B | B+ | ||
+3.49% | 26.85B | B | ||
+0.65% | 25.82B | A- | ||
+16.55% | 24.74B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALGN Stock
- Ratings Align Technology, Inc.